Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients.
Cattrini C, Rubagotti A, Zinoli L, Cerbone L, Zanardi E, Capaia M, Barboro P, Boccardo F. Cattrini C, et al. Among authors: rubagotti a. Cancers (Basel). 2019 Sep 13;11(9):1365. doi: 10.3390/cancers11091365. Cancers (Basel). 2019. PMID: 31540293 Free PMC article.
Safety of antiandrogen therapy for treating prostate cancer.
Ricci F, Buzzatti G, Rubagotti A, Boccardo F. Ricci F, et al. Among authors: rubagotti a. Expert Opin Drug Saf. 2014 Nov;13(11):1483-99. doi: 10.1517/14740338.2014.966686. Epub 2014 Oct 1. Expert Opin Drug Saf. 2014. PMID: 25270521 Review.
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes.
Cavo A, Rubagotti A, Zanardi E, Fabbroni C, Zinoli L, Di Meglio A, Arboscello E, Bellodi A, Spallarossa P, Cattrini C, Messina C, Boccardo F. Cavo A, et al. Among authors: rubagotti a. Ther Adv Med Oncol. 2018 Jan 9;10:1758834017745819. doi: 10.1177/1758834017745819. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29383035 Free PMC article.
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer.
Cattrini C, Barboro P, Rubagotti A, Zinoli L, Zanardi E, Capaia M, Boccardo F. Cattrini C, et al. Among authors: rubagotti a. Transl Oncol. 2020 Jul;13(7):100789. doi: 10.1016/j.tranon.2020.100789. Epub 2020 May 14. Transl Oncol. 2020. PMID: 32416542 Free PMC article.
Targeting androgen-independent pathways: new chances for patients with prostate cancer?
Cattrini C, Zanardi E, Vallome G, Cavo A, Cerbone L, Di Meglio A, Fabbroni C, Latocca MM, Rizzo F, Messina C, Rubagotti A, Barboro P, Boccardo F. Cattrini C, et al. Among authors: rubagotti a. Crit Rev Oncol Hematol. 2017 Oct;118:42-53. doi: 10.1016/j.critrevonc.2017.08.009. Epub 2017 Aug 30. Crit Rev Oncol Hematol. 2017. PMID: 28917268 Review.
Switching to aromatase inhibitors in early breast cancer.
Boccardo F, Rubagotti A. Boccardo F, et al. Among authors: rubagotti a. Lancet. 2007 Feb 17;369(9561):533-5. doi: 10.1016/S0140-6736(07)60201-3. Lancet. 2007. PMID: 17307082 No abstract available.
121 results